MDMA or XTC may well provide relief to people suffering from post-traumatic stress disorder (PTSD). As we’ve posted before, small trial studies have shown the potentially beneficial effects when using ecstasy in a supervised manner and in conjunction with intense psychotherapy.
Now the phase-II study is well under way and the focus is on US war veterans that are heavily traumatized by the horrors they’ve seen during their tour of duty.
The study by the Multidisciplinary Association for Psychedelic Studies (MAPS) is performed in a clinic in Charleston, South Carolina. It aims to gain the approval to make MDMA a prescription medicine, though when –and if- this will happen remains uncertain, in light of all the taboos associated with XTC and psychedelics in general.
Current medication for distressed combat veterans includes antidepressants such as sertraline and paroxetine, which studies have shown to sometimes actually worsen depressions as opposed to non-medicated patients.
Rick Doblin, the director of MAPS, envisions a day when ecstasy can be picked up at the corner drug store.